News

2101 items found, showing page 3 of 176

Scottish Enterprise

Glox Therapeutics awarded £1m PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.

1. EnergyWorks partners and minister

Construction begins on £9 million ETZ EnergyWorks in Aberdeen

Market-leading facility, backed with UK, Scottish Government, Scottish Enterprise and industry funding, will rapidly scale-up green energy firms

Sensor team L-R Industrial Champion John Gilhooly Dr Philip Hands Prof Marc Desmulliez research assistant Jason Norman

New flexible sensor can improve compression therapy

Scottish scientists have developed a low-cost, flexible device that can help prevent blood clots for patients after an operation.

Scottish Enterprise

Funding boost for Scottish bio-based manufacturing as second round of Innovate UK Launchpad for Scotland opens

Businesses innovating in Scotland’s thriving bio-based manufacturing industry are being invited to apply for support packages of between £25,000 and £1 million as Innovate UK opens Round 2 of its pioneering Launchpad funding programme. 

tech-school-team-shot-oct24

Dundee Tech School opens doors to class of 2024

Scottish Widows inducted the second wave of future tech stars on Tuesday 29 October at its Dundee Tech School, following the success its first year of trainees achieved.

Kynos-L-R-Damian-Mole-and-Scott-Webster 2024-10-28-100638 qksq f0cae20733639381437e27150d8fe19e

Dr. Falk Pharma acquires spinout Kynos Therapeutics to develop its novel KMO inhibitors for acute pancreatitis

Dr. Falk Pharma GmbH today announced completion of the acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel KMO inhibitors for acute and chronic inflammatory diseases.

Montrose-Commercial-Park-from-above-768x576

Montrose Port Authority Acquires Key Sites with Major Multi-Million-Pound Expansion for Renewable Energy Growth

Montrose Port Authority (MPA) is set to embark on a major expansion with the acquisition of Montrose Commercial Park and the adjacent former Charleton Maternity Home site.

Scottish Enterprise

Scottish start-ups go global

Twelve Scottish business founders are being given the opportunity to showcase their products and attract international investment in one of the world’s biggest tech economies.

Concept image for Neuranics MMG Wristband

Neuranics announces £2.4m project to revolutionise human-machine interfaces with Scottish Enterprise support

Neuranics has secured an £800,000 grant from Scottish Enterprise (SE) to support a £2.4 million project aimed at transforming how humans interact with machines through innovative wristband technology.

LeapAI 2

New investment in Leap Automation powers industrial AI robotics

A new £7.9m investment, led by £3.5m from the Scottish National Investment Bank, will enable scale and growth for Leap Automation Ltd, an emerging leader in low-cost industrial AI robotics.